title: Hatteras rounds up $90 million to lead biotech rebound in North Carolina.
authors.forename: Deborah
authors.initials: D
authors.lastname: Erickson
mesh_terms: D001709:Biotechnology / Q000191:economics* / Q000458:organization & administration*; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration*; D006801:Humans; D009657:North Carolina; D012456:Salaries and Fringe Benefits